Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Amgen, ImmunoGen deal

December 24, 2012 8:00 AM UTC

Amgen exercised a third option for an exclusive, worldwide license to use ImmunoGen's Targeted Antibody Payload (TAP) technology to develop cancer therapeutics to an undisclosed target. TAP technology...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article